Literature DB >> 23011219

Clinical and anatomical correlates of gait dysfunction in Alzheimer's disease.

Javier Olazarán1, Juan Antonio Hernández-Tamames, Elena Molina, Pablo García-Polo, José Luis Dobato, Juan Álvarez-Linera, Pablo Martínez-Martín.   

Abstract

We conducted a cross-sectional study to investigate the clinical and anatomical correlates of gait dysfunction in advanced Alzheimer's disease (AD). A comprehensive clinical protocol that included cognitive, functional, behavioral, and motor variables was administered to patients with probable AD (n = 100), possible AD (n = 17), and AD with cerebrovascular disease (AD + CVD) (n = 27). Gait dysfunction was evaluated with the Rating Scale for Gait Evaluation in Cognitive Deterioration and magnetic resonance imaging was analyzed in 94 patients (volumetry study) and 78 patients (diffusion tensor imaging study). Univariate correlations, multivariate regression, and statistical parametric mapping analyses were conducted in the total sample and in the subsample of patients with probable AD. Mean age was 82.5 (SD 6.3, range 56 to 98), 83.3% were female patients, and 95.1% displayed moderate to severe dementia. Parkinsonism, patient setting (nursing home), dementia severity, apathy, and (worse) cognitive performance significantly predicted gait dysfunction in the total sample (p < 0.05, R(2) = 0.58), whereas parkinsonism, patient setting, and limb weakness due to non-AD conditions predicted gait dysfunction in probable AD (p < 0.05, R(2) = 0.57). Gait dysfunction was related to atrophy in the motor cortex, the middle cingulate, the anterior insula, the right caudate (total sample only), and the anterior lobe of the cerebellum (p < 0.01, corrected). Significant correlations were also observed between gait dysfunction and damage in several white matter locations (p < 0.001, uncorrected). The present results are congruent with a model of multi-system gray matter degeneration, with progressive damage to critical regions (i.e., motor cortex, cingulate, insula, and cerebellum) producing gait dysfunction and, eventually, gait loss in AD.

Entities:  

Mesh:

Year:  2013        PMID: 23011219     DOI: 10.3233/JAD-2012-121207

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  11 in total

1.  Symptoms of Apathy Independently Predict Incident Frailty and Disability in Community-Dwelling Older Adults.

Authors:  Emmeline Ayers; Miriam Shapiro; Roee Holtzer; Nir Barzilai; Sofiya Milman; Joe Verghese
Journal:  J Clin Psychiatry       Date:  2017-05       Impact factor: 4.384

2.  Daily Physical Activity Patterns During the Early Stage of Alzheimer's Disease.

Authors:  Vijay R Varma; Amber Watts
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Neural Mechanisms of Motor Dysfunction in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review.

Authors:  Vincent Koppelmans; Benjamin Silvester; Kevin Duff
Journal:  J Alzheimers Dis Rep       Date:  2022-06-22

4.  Early manifestation of gait alterations in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Anna Csiszar; Zoltan Ungvari; Stefano Tarantini; Adam Nyul-Toth; Jordan DelFavero; Peter Mukli; Amber Tarantini; Anna Ungvari; Andriy Yabluchanskiy
Journal:  Geroscience       Date:  2021-06-23       Impact factor: 7.713

Review 5.  Technologies for Advanced Gait and Balance Assessments in People with Multiple Sclerosis.

Authors:  Camille J Shanahan; Frederique M C Boonstra; L Eduardo Cofré Lizama; Myrte Strik; Bradford A Moffat; Fary Khan; Trevor J Kilpatrick; Anneke van der Walt; Mary P Galea; Scott C Kolbe
Journal:  Front Neurol       Date:  2018-02-02       Impact factor: 4.003

6.  An Examination of Brain Abnormalities and Mobility in Individuals with Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Barbara L Fischer; Rhonda Bacher; Barbara B Bendlin; Alex C Birdsill; Martina Ly; Siobhan M Hoscheidt; Richard J Chappell; Jane E Mahoney; Carey E Gleason
Journal:  Front Aging Neurosci       Date:  2017-04-05       Impact factor: 5.750

7.  Physical Performance in Memory Clinic Patients: The Potential Role of the White Matter Network.

Authors:  Jurre H Verwer; Yael D Reijmer; Huiberdina L Koek; Geert Jan Biessels
Journal:  J Am Geriatr Soc       Date:  2019-05-28       Impact factor: 5.562

Review 8.  Brain imaging of locomotion in neurological conditions.

Authors:  Gilles Allali; Helena M Blumen; Hervé Devanne; Elvira Pirondini; Arnaud Delval; Dimitri Van De Ville
Journal:  Neurophysiol Clin       Date:  2018-10-25       Impact factor: 3.734

9.  Comparative Incidence of Conformational, Neurodegenerative Disorders.

Authors:  Jesús de Pedro-Cuesta; Alberto Rábano; Pablo Martínez-Martín; María Ruiz-Tovar; Enrique Alcalde-Cabero; Javier Almazán-Isla; Fuencisla Avellanal; Miguel Calero
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

10.  Targeting Alzheimer's Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies.

Authors:  Ming Tong; Cesar Dominguez; John Didsbury; Suzanne M de la Monte
Journal:  J Alzheimers Dis Parkinsonism       Date:  2016-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.